Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Peringkat dalam Saham
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Harga Saham
$20.91
Kapitalisasi Pasar
$7.57B
Perubahan (1 hari)
-8.26%
Perubahan (1 tahun)
41.25%
Negara
CN
Perdagangan Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategori
Healthcare
Pendapatan untuk Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Pendapatan pada Jun 2026 TTM: $1.06B
Menurut laporan keuangan terbaru dari Asymchem Laboratories (Tianjin) Co., Ltd., pendapatan saat ini (TTM) adalah $1.06B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $795.26M penurunan dibandingkan dengan pendapatan pada tahun 2023 yang sebesar $1.11B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Asymchem Laboratories (Tianjin) Co., Ltd. dari 2011 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $1.06B | 11.34% |
| 2025 | $953.37M | 19.88% |
| 2024 | $795.26M | -28.06% |
| 2023 | $1.11B | -25.46% |
| 2022 | $1.48B | 103.50% |
| 2021 | $728.79M | 51.78% |
| 2020 | $480.16M | 35.91% |
| 2019 | $353.28M | 32.44% |
| 2018 | $266.75M | 21.96% |
| 2017 | $218.72M | 37.65% |
| 2016 | $158.90M | 24.23% |
| 2015 | $127.91M | 10.62% |
| 2014 | $115.63M | 29.23% |
| 2013 | $89.48M | 31.47% |
| 2012 | $68.06M | 5.76% |
| 2011 | $64.35M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $12.62B | 1,089.29% |
US
|
|
| $2.23B | 109.89% |
US
|
|
| $15.74B | 1,383.22% |
AU
|
|
| $9.57B | 801.80% |
BE
|
|
| $6.02B | 467.25% |
NL
|
